Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Uni-Bio Science Group Ltd. ( (HK:0690) ) has shared an update.
Uni-Bio Science Group Ltd. has announced a board meeting scheduled for March 27, 2025, to approve the company’s financial results for the year ending December 31, 2024, and to discuss the potential recommendation of a final dividend. This meeting is crucial for stakeholders as it will provide insights into the company’s financial health and strategic decisions, potentially impacting its market positioning and investor confidence.
More about Uni-Bio Science Group Ltd.
Uni-Bio Science Group Ltd. is a company incorporated in the Cayman Islands, operating in the biotechnology industry. The company focuses on developing and commercializing biopharmaceutical products, catering to the healthcare market.
YTD Price Performance: 16.67%
Average Trading Volume: 8,436,312
Technical Sentiment Consensus Rating: Sell
Current Market Cap: HK$417M
See more insights into 0690 stock on TipRanks’ Stock Analysis page.